The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it ...

Israeli scientists have uncovered, for the first time, how breast cancer cells adapt to and survive in the brain, Tel Aviv University announced. The discovery could pave the way for new treatments, ...